Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-PM-PBB3 and 18F-florbetapir PET in Alzheimer's Disease
NCT04305210Phase 2Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Dec 2019
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of florzolotau in Alzheimer's disease (AD), sponsored by Chang Gung Memorial Hospital. Status: unknown.
02
Drugs
florzolotau
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT04305210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04305210.